Partner Content Partner Content Tom Parke to lead a workshop on the new FDA draft guidance during Adaptive Designs in Clinical Trials 2019
Partner Content Partner Content Key Pharmaceuticals Ltd to lead a workshop on Parallel Trade... Key Pharmaceuticals Ltd to lead a workshop
Partner Content Partner Content four weeks to go until Europe’s only Parallel Trade event Parallel Trade conference 2019
Partner Content Partner Content Registration opens for SMi’s 2nd Injectable Drug Delivery 20... Injectable Drug Delivery Conference 2019
Partner Content Partner Content Hot Sessions You Cannot Afford to Miss at 11th Pre-Filled Sy... Just 2 weeks remain until Europe's leading conference on Pre-Filled Syringes & Injectable Drug Devices takes place in London!
Partner Content Partner Content Pfizer’s vice president & Head of Early Clinical Develop... Adaptive Designs in Clinical Trials 2019
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
